Risk assessment of pregnant patients with heart disease: mWHO vs CARPREG II risk scores
Rev Esp Cardiol (Engl Ed). 2025 Jan 22:S1885-5857(25)00019-2.
doi: 10.1016/j.rec.2025.01.002.
Online ahead of print.
[Article in
English,
Spanish]
Affiliations
- 1 Department of Cardiology, Vall d'Hebron University Hospital, Barcelona, Spain.Universitat Autònoma de Barcelona, Spain; Integrated Hospital Vall d'Hebron-Hospital Sant Pau Adult Congenital Heart Disease Unit, Spain; Centro de Investigación Biomédica en Red en Enfermedades Cardiovasculares (CIBERCV), Instituto de Salud Carlos III, Madrid, Spain; European Reference Network for rare, low-prevalence, or complex diseases of the heart (ERN GUARD-Heart), Spain. Electronic address: tonyapijuan@hotmail.com.
- 2 Department of Cardiology, Vall d'Hebron University Hospital, Barcelona, Spain.Universitat Autònoma de Barcelona, Spain; Centro de Investigación Biomédica en Red en Enfermedades Cardiovasculares (CIBERCV), Instituto de Salud Carlos III, Madrid, Spain; European Reference Network for rare, low-prevalence, or complex diseases of the heart (ERN GUARD-Heart), Spain.
- 3 Department of Cardiology Arnau de Vilanova University Hospital, Lleida, Spain; Department of Medicine, Universitat Autònoma Barcelona, Spain.
- 4 Department of Obstetrics and Gynaecology, Maternal-Fetal Medicine Unit, Vall d'Hebron University Hospital, Barcelona, Spain. Universitat Autònoma de Barcelona, Spain.
No abstract available